DMII
Drugs Made In America Acquisition II Corp.Company with tickers: DMII, DMIIR, DMIIU
CIK
2040475
Shares Outstanding
65,575,000
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-09-26 | Prasad Sridhar G. | Director | Other | 100,000 |
| 2025-09-26 | Shulgan Myron W. | Director | Other | 100,000 |
| 2025-09-26 | Worman Glenn C. | CFO | Other | 100,000 |
| 2025-09-26 | Stockwell Lynn | Director, CEO and Exe. Chair of Board, 10% Owner | Sell | 7,966,667 |
| 2025-09-26 | Stockwell Lynn | Director, CEO and Exe. Chair of Board, 10% Owner | Buy | 700,000 |
| 2025-09-26 | Stockwell Lynn | Director, CEO and Exe. Chair of Board, 10% Owner | Other | 400,000 |
| 2025-09-26 | Stockwell Lynn | Director, CEO and Exe. Chair of Board, 10% Owner | Buy | 700,000 |
| 2025-09-26 | Do Catherine | Director | Other | 100,000 |
| 2025-09-26 | Drugs Made In America Acquisition II LLC | 10% Owner | Buy | 700,000 |
| 2025-09-26 | Drugs Made In America Acquisition II LLC | 10% Owner | Sell | 7,966,667 |
| 2025-09-26 | Drugs Made In America Acquisition II LLC | 10% Owner | Other | 400,000 |
| 2025-09-26 | Drugs Made In America Acquisition II LLC | 10% Owner | Buy | 700,000 |
| 2025-09-24 | Drugs Made In America Acquisition II LLC | 10% Owner | Other | 14,375,000 |
| 2025-09-24 | Do Catherine | Director | Other | 0 |
| 2025-09-24 | Worman Glenn C. | CFO | Other | 0 |
| 2025-09-24 | Shulgan Myron W. | Director | Other | 0 |
| 2025-09-24 | Stockwell Lynn | Director, CEO and Exe. Chair of Board, 10% Owner | Other | 14,375,000 |
| 2025-09-24 | Prasad Sridhar G. | Director | Other | 0 |